[1]
D. GUVVALI and D. MOHANTY, “A QUALITY BY DESIGN DRIVEN DEVELOPMENT AND CHARACTERIZATION OF PALBOCICLIB-LOADED MESOPOROUS SILICA NANOPARTICLES IN HEPATOCELLULAR CARCINOMA THERAPY: ASSESSMENT OF CYTOTOXIC AND APOPTOTIC EFFECTS ON HEPG2 CELL LINE”, Int J App Pharm, vol. 18, no. 3, Apr. 2026.